Drug Shortage Report for ACT METHYLPHENIDATE ER
Report ID | 65990 |
Drug Identification Number | 02441934 |
Brand name | ACT METHYLPHENIDATE ER |
Common or Proper name | METHYLPHENIDATE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
Strength(s) | 18MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-03-26 |
Estimated end date | 2024-02-10 |
Actual end date | 2024-02-12 |
Shortage status | Resolved |
Updated date | 2024-02-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-11-01 | English | Compare |
v2 | 2018-11-01 | French | Compare |
v3 | 2018-11-01 | English | Compare |
v4 | 2018-11-01 | French | Compare |
v5 | 2018-11-01 | English | Compare |
v6 | 2018-11-01 | French | Compare |
v7 | 2019-01-03 | English | Compare |
v8 | 2019-01-03 | French | Compare |
v9 | 2019-03-14 | English | Compare |
v10 | 2019-03-14 | French | Compare |
v11 | 2019-08-22 | English | Compare |
v12 | 2019-08-22 | French | Compare |
v13 | 2019-10-10 | English | Compare |
v14 | 2019-10-10 | French | Compare |
v15 | 2019-10-10 | English | Compare |
v16 | 2019-10-10 | French | Compare |
v17 | 2019-10-10 | English | Compare |
v18 | 2019-10-10 | French | Compare |
v19 | 2019-11-21 | English | Compare |
v20 | 2019-11-21 | French | Compare |